Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins
Journal Title: Women's Health – Open Journal - Year 2017, Vol 3, Issue 1
Abstract
The family of therapeutic glycoproteins contains many members. Some of them have become valuable therapeutic agents in saving the countless number of human lives from some of the most dreadful diseases. They are increasingly taking a center stage among biotherapeutics. The technologies of glycoengineering are making a further impact by modifying the glycan moieties, which make them biologically more active and increase their effectiveness and pharmacokinetics, etc. Human Chorionic Gonadotropin (hCG) has been used in reproductive medicine for the last several decades. The paradigm shift on the hCG actions has created additional therapeutic opportunities against many menacing and dangerous diseases that are no less important than the ones treated by some of the prominent members of the therapeutic glycoproteins family. However, to the best of the authors’ knowledge, hCG has never been included in this family or tapped the potential of glycoengineering to make hCG even more therapeutically effective than the currently used preparations. It is time to include hCG in the family and begin glycoengineering on recombinant hormone.
Authors and Affiliations
C. V. Rao
Keywords
Related Articles
- EP ID EP554903
- DOI 10.17140/WHOJ-3-119
- Views 121
- Downloads 0
Quality of Antenatal Care and Outcome of Pregnancy in a Semi-Urban Area in Fako Division, Cameroon: A Cross-Sectional Study
Introduction: The outcome of pregnancy depends, to a large extent, on the availability and effectiveness of antenatal care. Unskilled care before, during and after child birth, late start and inconsistent attendance of A...
Vitamin D Revisited: Impact on Osteoporosis
With the now widespread recognition that the prevention and treatment of osteoporosis has a major impact on healthcare, the various components and contributing factors to this condition is the subject of many recent and...
From Menstruation to Menopause: Have We Medicalised the Physiology of Normalcy? (Part 1)
UNDERSTANDING THE RELATIONSHIP BETWEEN MENSTRUATION AND MENOPAUSE Although, there are exceptions to the rule, women generally experience ‘menopause’ between the ages of 48 to 54, within which time the cessation of all me...
Risk Factors and Barriers to Male Involvement in the Choice of Family Planning Methods in the Buea Health District, South West Region,Cameroon: A Cross-Sectional Study in a Semi-Urban Area
Background: Family Planning (FP) promotion and services are often focused on women, but nonetheless men have an important role to play also. Engaging men in family planning programs and services has the potential to impr...
Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins
The family of therapeutic glycoproteins contains many members. Some of them have become valuable therapeutic agents in saving the countless number of human lives from some of the most dreadful diseases. They are increasi...